Tag: Integra

Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook
Financial

Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results and 2017 Outlook

PLAINSBORO, N.J., Jan. 10, 2017 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announced today that it has signed a definitive agreement to acquire Derma Sciences Inc. (Nasdaq:DSCI) for a price of $7.00 per share of Derma Sciences common stock in cash. “Derma Sciences’ […]

Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion
Financial

Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion

PLAINSBORO, N.J., Dec. 07, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation(NASDAQ:IART) today announced that it has increased its credit facility with its bank group led by Bank of America, N.A. The expanded and extended credit facility includes the following terms: An increase in the credit facility from $1.1 billion […]

Integra LifeSciences Announces Key Executive Appointments
Extremities Neuro

Integra LifeSciences Announces Key Executive Appointments

PLAINSBORO, N.J., Dec. 05, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced key executive appointments effective December 1, 2016. Robert T. Davis, Jr., corporate vice president and president, Specialty Surgical Solutions (SSS), has been named corporate vice president and president, Orthopedics and Tissue Technologies. Dan Reuvers, corporate […]

Integra LifeSciences Announces Plans for a Two-For-One Stock Split and Increase in Authorized Shares
Financial

Integra LifeSciences Announces Plans for a Two-For-One Stock Split and Increase in Authorized Shares

PLAINSBORO, N.J., Oct. 27, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that its Board of Directors has recommended an increase in the number of authorized shares and a two-for-one stock split. “The recommendation from the board of directors acknowledges the inflection point the Company has gone […]

Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft® Dermal Regeneration Matrix and PriMatrix® Dermal Repair Scaffold at Symposium on Advanced Wound Care (SAWC) Fall Meeting
Biologics

Integra LifeSciences Organizes Hands-on Wound Workshop on Best Practices for Omnigraft® Dermal Regeneration Matrix and PriMatrix® Dermal Repair Scaffold at Symposium on Advanced Wound Care (SAWC) Fall Meeting

PLAINSBORO, N.J., Oct. 17, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) recently organized a hands-on regenerative wound management workshop at the Symposium on Advanced Wound Care (SAWC) Fall meeting in Las Vegas, Nevada. The workshop, led by renowned wound care experts John Lantis, MD, and Paul Kim, DPM, focused […]

Integra LifeSciences Announces First Clinical Uses of Cadence™ Total Ankle System in Europe
Extremities

Integra LifeSciences Announces First Clinical Uses of Cadence™ Total Ankle System in Europe

Plainsboro, N.J., Sept. 20, 2016 (Globe Newswire) (NASDAQ:IART), a leading global medical technology company, today announced that the first three procedures using the Integra® Cadence™ Total Ankle System in Europe were successfully completed since July 13, 2016 by Dr. Thibaut Leemrijse, of the Foot and Ankle Institute, Parc Léopold Clinic, […]

Integra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today
Extremities

Integra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today

PLAINSBORO, N.J., Aug. 01, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its recently introduced product, Integra® Omnigraft™ Dermal Regeneration Matrix, has been recognized byPodiatry Today as one of the “Top Ten Innovations in Podiatry” in 2016.  Podiatry Today is […]

Integra LifeSciences Reports Second Quarter 2016 Financial Results
Financial

Integra LifeSciences Reports Second Quarter 2016 Financial Results

PLAINSBORO, N.J., July 28, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported its financial results for the second quarter ending June 30, 2016. Highlights: Second quarter revenue increased 17.2% over the prior-year quarter to $249.3 million and organic revenue increased 10.7%; GAAP gross margin was 64.1% and adjusted […]

Integra LifeSciences launches Integra® Fin-Lock™ Glenoid for the Titan™ Modular Shoulder System
Recon

Integra LifeSciences launches Integra® Fin-Lock™ Glenoid for the Titan™ Modular Shoulder System

PLAINSBORO, N.J., May 23, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, today announced the launch of the Integra® Fin-Lock™ Glenoid. This addition to the Titan™ Modular Shoulder System increases the glenoid offerings to include features intended to help maximize long-term fixation and […]

Integra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release
Regulatory

Integra LifeSciences Receives FDA Approval for Integra® Omnigraft™ Dermal Regeneration Matrix, Clearing the Way for Commercial Release

PLAINSBORO, N.J., May 11, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company has received approval from the  U.S. Food and Drug Administration (FDA) for the packaging of its new product, Integra® Omnigraft™ Dermal Regeneration Matrix, which clears the […]

Integra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch
Regulatory

Integra LifeSciences Provides Update for Omnigraft™ Commercialization Plans, Including Expectations for an Earlier Launch

PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the Company is prepared to launch Omnigraft™ Dermal Regeneration Matrix in June 2016, pending receipt of final U.S. Food and Drug Administration (FDA) packaging approval. The FDA approved […]

Integra LifeSciences Reports First Quarter 2016 Financial Results
Financial

Integra LifeSciences Reports First Quarter 2016 Financial Results

PLAINSBORO, N.J., April 27, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART) today reported its financial results for the first quarter ending March 31, 2016. Highlights: First quarter revenue increased 16.9% over the prior-year quarter to $236.8 million and organic revenue increased 8.9%; Adjusted gross margins reached a record high; […]

Integra LifeSciences Announces Initial Clinical Use of the Cadence™ Total Ankle System in the United States
Extremities

Integra LifeSciences Announces Initial Clinical Use of the Cadence™ Total Ankle System in the United States

PLAINSBORO, N.J., April 26, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that the first ten procedures using the Integra® CadenceTM Total Ankle System were successfully completed by Dr. Selene Parekh and Dr. David Pedowitz. The Cadence Total Ankle System was […]

Integra LifeSciences Announces Agreement with Vomaris Wound Care, Inc. to Commercialize VolTAC™ Antimicrobial Wound Dressing
Top Stories

Integra LifeSciences Announces Agreement with Vomaris Wound Care, Inc. to Commercialize VolTAC™ Antimicrobial Wound Dressing

PLAINSBORO, N.J., April 14, 2016 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its subsidiary, Integra LifeSciences Corporation, has entered into an agreement with Vomaris Wound Care, Inc., a company specializing in microcurrent solutions for the advanced wound care market. Vomaris’s […]